Presentation Information
[S3-5]The Contribution of Aging to the Development of Immune-Related Adverse Events Associated with Cancer Immunotherapy
○Hirotake Tsukamoto1 (1. Center for Cancer Immunotherapy and Immunobiology, Kyoto University (Japan))
Password required to view
Comment
To browse or post comments, you must log in.Log in
